Kyverna Therapeutics

Founded in 2018 and headquartered in Emeryville, California, Kyverna Therapeutics is a clinical-stage biopharmaceutical company operating in the biotechnology research industry, dedicated to liberating autoimmune patients through the curative potential of cell therapy. Its lead candidate, miv-cel (mivocabtagene autoleucel, KYV-101), an autologous CD19-targeting CAR T-cell therapy, has shown the potential to fundamentally change treatment approaches across multiple B-cell-driven autoimmune diseases. The company is advancing a potentially first-in-class neuroimmunology franchise, having recently completed a registrational trial in stiff person syndrome and currently conducting an ongoing registrational trial for generalized myasthenia gravis. Kyverna is also pursuing additional KYSA and investigator-initiated trials, including in multiple sclerosis and rheumatoid arthritis, to guide future priority indications, while its next-generation pipeline explores novel CAR T-cell innovations aimed at improving patient access and experience. With more than 160 employees, Kyverna continues to expand its research and clinical efforts in the autoimmune disease space.

• 

  Kyverna Therapeutics

  Today

  Vice president, marketing

  remote, United States

  $320k – $350k/yrFull TimeVP / C-level

  Apply
• 

  Kyverna Therapeutics

  2 days ago

  Director, medical science liaison (west coast)

  remote, CA, United States

  $220k – $250k/yrFull TimeDirector

  Apply
• 

  Kyverna Therapeutics

  14 days ago

  Sr. medical director, clinical development

  remote, United States

  $330k – $370k/yrFull TimeDirector

  Apply
• 

  Kyverna Therapeutics

  19 days ago

  Safety writer/scientist – contract

  remote, United States

  $343k – $383k/yrPart TimeSenior (5+ years)

  Apply
• 

  Kyverna Therapeutics

  20 days ago

  Senior director, clinical science

  remote, United States

  $260k – $290k/yrFull TimeDirector

  Apply